| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
|
N Engl J Med
|
2011
|
10.79
|
|
2
|
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
|
Lancet
|
2004
|
9.24
|
|
3
|
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
|
Lancet
|
2007
|
4.83
|
|
4
|
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.
|
Lancet
|
2005
|
4.68
|
|
5
|
Mass treatment with single-dose azithromycin for yaws.
|
N Engl J Med
|
2015
|
3.84
|
|
6
|
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial.
|
Lancet
|
2008
|
3.31
|
|
7
|
Community-acquired bacteremia among children admitted to a rural hospital in Mozambique.
|
Pediatr Infect Dis J
|
2009
|
2.83
|
|
8
|
Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial.
|
Lancet
|
2012
|
2.81
|
|
9
|
Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill?
|
Clin Infect Dis
|
2012
|
2.53
|
|
10
|
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children.
|
J Infect Dis
|
2009
|
2.36
|
|
11
|
A 10 year study of the cause of death in children under 15 years in Manhiça, Mozambique.
|
BMC Public Health
|
2009
|
1.76
|
|
12
|
Malaria in rural Mozambique. Part I: children attending the outpatient clinic.
|
Malar J
|
2008
|
1.68
|
|
13
|
Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children.
|
PLoS One
|
2009
|
1.64
|
|
14
|
Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination.
|
Malar J
|
2013
|
1.57
|
|
15
|
Detection of Streptococcus pneumoniae and Haemophilus influenzae type B by real-time PCR from dried blood spot samples among children with pneumonia: a useful approach for developing countries.
|
PLoS One
|
2013
|
1.50
|
|
16
|
Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis.
|
Am J Trop Med Hyg
|
2011
|
1.44
|
|
17
|
Invasive non-typhoidal Salmonella in Mozambican children.
|
Trop Med Int Health
|
2009
|
1.33
|
|
18
|
Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon.
|
PLoS One
|
2012
|
1.29
|
|
19
|
Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus.
|
Pediatr Infect Dis J
|
2011
|
1.25
|
|
20
|
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
|
J Infect Dis
|
2012
|
1.23
|
|
21
|
Profile: Manhiça Health Research Centre (Manhiça HDSS).
|
Int J Epidemiol
|
2013
|
1.20
|
|
22
|
Antimicrobial drug resistance trends of bacteremia isolates in a rural hospital in southern Mozambique.
|
Am J Trop Med Hyg
|
2010
|
1.13
|
|
23
|
Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors.
|
J Trop Pediatr
|
2009
|
1.13
|
|
24
|
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence.
|
Expert Opin Pharmacother
|
2012
|
1.10
|
|
25
|
Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial.
|
Vaccine
|
2011
|
1.07
|
|
26
|
Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial.
|
Vaccine
|
2007
|
1.05
|
|
27
|
Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor.
|
PLoS One
|
2011
|
1.03
|
|
28
|
Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area.
|
PLoS One
|
2010
|
1.02
|
|
29
|
Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study.
|
Malar J
|
2012
|
1.01
|
|
30
|
Plasmodium vivax malaria in Mali: a study from three different regions.
|
Malar J
|
2012
|
1.01
|
|
31
|
Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting.
|
Infect Immun
|
2009
|
1.00
|
|
32
|
Outcome predictors in treatment of yaws.
|
Emerg Infect Dis
|
2011
|
0.99
|
|
33
|
The role of age and exposure to Plasmodium falciparum in the rate of acquisition of naturally acquired immunity: a randomized controlled trial.
|
PLoS One
|
2012
|
0.99
|
|
34
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
35
|
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial.
|
PLoS One
|
2010
|
0.99
|
|
36
|
Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
|
Antimicrob Agents Chemother
|
2011
|
0.98
|
|
37
|
Advances in the diagnosis of endemic treponematoses: yaws, bejel, and pinta.
|
PLoS Negl Trop Dis
|
2013
|
0.97
|
|
38
|
Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients.
|
Am J Trop Med Hyg
|
2012
|
0.97
|
|
39
|
Inherent illnesses and attacks: an ethnographic study of interpretations of childhood Acute Respiratory Infections (ARIs) in Manhiça, southern Mozambique.
|
BMC Public Health
|
2011
|
0.96
|
|
40
|
Integrated vector management targeting Anopheles darlingi populations decreases malaria incidence in an unstable transmission area, in the rural Brazilian Amazon.
|
Malar J
|
2012
|
0.95
|
|
41
|
Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy.
|
Infect Immun
|
2011
|
0.93
|
|
42
|
Towards an effective malaria vaccine.
|
Arch Dis Child
|
2007
|
0.92
|
|
43
|
Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.
|
Malar J
|
2014
|
0.91
|
|
44
|
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
|
Malar J
|
2015
|
0.91
|
|
45
|
The impact of a filariasis control program on Lihir Island, Papua New Guinea.
|
PLoS Negl Trop Dis
|
2011
|
0.90
|
|
46
|
Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties.
|
Trop Med Int Health
|
2011
|
0.89
|
|
47
|
Osteoperiostitis in early yaws: case series and literature review.
|
Clin Infect Dis
|
2011
|
0.88
|
|
48
|
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
|
Malar J
|
2012
|
0.86
|
|
49
|
Inadequate efficacy of a new formulation of fosmidomycin-clindamycin combination in Mozambican children less than three years old with uncomplicated Plasmodium falciparum malaria.
|
Antimicrob Agents Chemother
|
2012
|
0.86
|
|
50
|
New treatment schemes for yaws: the path toward eradication.
|
Clin Infect Dis
|
2012
|
0.85
|
|
51
|
Challenges in recognition and diagnosis of yaws in children in Papua New Guinea.
|
Am J Trop Med Hyg
|
2011
|
0.84
|
|
52
|
Transcription of var genes other than var2csa in Plasmodium falciparum parasites infecting Mozambican pregnant women.
|
J Infect Dis
|
2011
|
0.84
|
|
53
|
High reliability in respiratory rate assessment in children with respiratory symptomatology in a rural area in Mozambique.
|
J Trop Pediatr
|
2013
|
0.84
|
|
54
|
Tolerability and safety of primaquine in Papua New Guinean children 1 to 10 years of age.
|
Antimicrob Agents Chemother
|
2012
|
0.83
|
|
55
|
Erythropoietin levels are not independently associated with malaria-attributable severe disease in Mozambican children.
|
PLoS One
|
2011
|
0.82
|
|
56
|
Health care utilization and attitudes survey in cases of moderate-to-severe diarrhea among children ages 0-59 months in the District of Manhica, southern Mozambique.
|
Am J Trop Med Hyg
|
2013
|
0.81
|
|
57
|
Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique.
|
Malar J
|
2014
|
0.81
|
|
58
|
Lower respiratory tract infections associated with rhinovirus during infancy and increased risk of wheezing during childhood. A cohort study.
|
PLoS One
|
2013
|
0.81
|
|
59
|
Severe malnutrition among children under the age of 5 years admitted to a rural district hospital in southern Mozambique.
|
Public Health Nutr
|
2013
|
0.79
|
|
60
|
Malaria-associated hypoglycaemia in children.
|
Expert Rev Anti Infect Ther
|
2014
|
0.78
|
|
61
|
Mycetoma caused by Nocardia yamanashiensis, Papua New Guinea.
|
Am J Trop Med Hyg
|
2012
|
0.77
|
|
62
|
Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique.
|
PLoS One
|
2011
|
0.77
|
|
63
|
Epidemiology, etiology, x-ray features, importance of co-infections and clinical features of viral pneumonia in developing countries.
|
Expert Rev Anti Infect Ther
|
2014
|
0.77
|
|
64
|
Malaria epidemiology in Lihir Island, Papua New Guinea.
|
Malar J
|
2013
|
0.77
|
|
65
|
Biomarker discovery for childhood infections: paving the way for a diagnostic revolution in the developing world.
|
Biomark Med
|
2014
|
0.76
|
|
66
|
Approaching the target: the path towards an effective malaria vaccine.
|
Mediterr J Hematol Infect Dis
|
2012
|
0.75
|
|
67
|
Mass Treatment with Single-Dose Azithromycin for Yaws.
|
N Engl J Med
|
2016
|
0.75
|
|
68
|
Correction: Detection of Streptococcus pneumoniae and Haemophilus influenzae Type B by Real-Time PCR from Dried Blood Spot Samples among Children with Pneumonia: A Useful Approach for Developing Countries.
|
PLoS One
|
2016
|
0.75
|
|
69
|
HMS-related hemolysis after acute attacks of Plasmodium vivax malaria.
|
Am J Trop Med Hyg
|
2011
|
0.75
|
|
70
|
Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
|
P N G Med J
|
2016
|
0.75
|
|
71
|
Carriage prevalence of Salmonella enterica serotype Typhi in gallbladders of adult autopsy cases from Mozambique.
|
J Infect Dev Ctries
|
2016
|
0.75
|
|
72
|
Developments in therapy and diagnosis of yaws and future prospects.
|
Expert Rev Anti Infect Ther
|
2013
|
0.75
|